Recombinant adenoviral vector disrupts surfactant homeostasis in mouse lung

Human Gene Therapy

Volumn 8, Issue 11, 1997, Pages 1331-1344

  Zsengellér, Zsuzsanna K ^a   Wert, Susan E ^a   Bachurski, Cindy J ^a   Kirwin, Kevin L ^a   Trapnell, Bruce C ^b   Whitsett, Jeffrey A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; MESSENGER RNA; SURFACTANT ASSOCIATED PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GENE TRANSFER; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; RESPIRATORY EPITHELIUM; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA;

EID: 0030819998     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.11-1331     Document Type: Article

References (67)

1. BAATZ, J.E., ELLEDGE, B., and WHITSETT, J.A. (1990). Surfactant protein SP-B induces ordering at the surface of model membrane bilayers. Biochemistry 29, 6714-6720.
2. BACHURSKI, C.J., PRYHUBER, G.S., GLASSER, S.W., KELLY, S.E., and WHITSETT, J.A. (1995). Tumor necrosis factor-α inhibits surfactant protein C gene transcription. J. Biol. Chem. 270, 19402-19407.
3. BAUGHMAN, R.P., STERNBERG, R.I., HULL, W., BUCHSBAUM, J.A., and WHITSETT, J. (1993). Decreased surfactant protein-A inpatients with bacterial pneumonia. Am. Rev. Respir. Dis. 147, 653-657.
4. BOUCHER, R.C., KNOWLES, M.R., JOHNSON, L.G., OLSEN, J.C., PICKLES R., WILSON, J.M., ENGELHARDT, J., YANG, Y., and GROSSMAN, M. (1994). Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. Hum. Gene Ther. 5, 615-639.
5. BOUT, A., PERRICAUDET, M., BASKIN, G., IMLER, J., SCHOLTE, B.J., PAVIRANI, A., and VALERIO, D. (1994). Lung gene therapy: In vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. Hum. Gene Ther. 5, 3-10.
6. BREEN, E., SHULL, S., BURNE, S., ABSHER, M., KELLEY, J., PHAN, S., and CUTRONEO, K.R. (1992). Bleomycin regulation of transforming growth factor-β mRNA in rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 6, 146-152.
7. BRODY, S.L., METZGER, M., DANEL, C., ROSENFELD, M.A., and CRYSTAL, R.G. (1994). Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 821-836.
8. CLARK, J.C., WERT, S.E., BACHURSKI, C.J., STAHLMAN, M.T., STRIPP, B.R., WEAVER, T.E., and WHITSETT, J.A. (1995). Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc. Natl. Acad. Sci. USA 92, 7794-7798.
9. CLARK, J.C., WEAVER, T.E., IWAMOTO, H.S., IKEGAMI, M., JOBE, A.J., HULL, W.M., WHITSETT, J.A. (1997). Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. Am. J. Respir. Cell Mol. Biol. 16, 45-52.
10. COALSON, J.J., KING, R.J., YANG, F., WINTER, V., WHITSETT, J.A., DELEMOS, R.A. and SEIDNER, S.R. (1995). SP-A deficiency in primate model of bronchopulmonary dysplasia with infection: In situ mRNA and immunostains. Am. J. Respir. Crit. Care Med. 151, 854-866.
11. CRYSTAL, R.G., McELVANEY, N.G., ROSENFELD, M.A., CHU, C., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
12. D'AMORE-BRUNO, M.A., WIKENHEISER, K.A., CARTER, J.E., CLARK, J.C., and WHITSETT, J.A. (1992). Sequence, ontogeny and cellular localization of murine surfactant protein SP-B mRNA. Am. J. Physiol.: Lung Cell Mol. Physiol. 262, L40-L47.
13. DARGAVILLE, P.A., SOUTH, M., and McDOUGALL, P.N. (1996). Surfactant abnormalities in infants with severe viral bronchiolitis. Arch. Dis. Child. 75, 133-136.
14. DRANOFF, G., CRAWFORD, A.D., SADELAIN, M., REAM, B., RASHID, A., BRONSON, R.T., DICKERSIN, G.R., BACHURSKI, C.J., MARK, E.L., WHITSETT, J.A., and MULLIGAN, R.C. (1994). Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264, 713-716.
15. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory responses in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
16. FISHER, A.B. (1988). Intracellular production of oxygen free radicals. In Oxygen Radicals and Tissue Injury. B. Halliwell, ed. (Federation of American Societies for Experimental Biology, Bethesda, MD) pp. 34-39.
17. GINSBERG, H.S., LUNDHOLM-BEAUCHAMP, U., HORSWOOD, R.L., PERNIS, B., WOLD, W.S.M., CHANCOCK, R.M., and PRINCE, G.A. (1989). Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86, 3823-3827.
18. GINSBERG, H.S., MOLDAWER, L.L., SEGHAL, P.B., REDINGTON, M., KILIAN, P.L., CHANOCK, R.M., and PRINCE, G.A. (1991). A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88, 1651-1655.
19. GLASSER, S.W., KORFHAGEN, T.R., CLARK, J.C., BRUNO, M.D., MCMAHAN, M.J., and WHITSETT, J.A. (1990). Structure nucleotide sequence and tissue-specific expression of murine gene encoding pulmonary surfactant protein-C. Am. Rev. Respir. Dis. 141, A693.
20. GREGORY, T.J., LONGMORE, W.J., MOXLEY, M.A., WHITSETT, J.A., REED, C.R., FOWLER, A.A., HUDSON, L.D., MAUNDER, R.J., CRIM, C., and HYERS, T.M. (1991). Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 188, 1976-1981.
21. HOROWITZ, S., WATKINS, R.H., AUTEN, R.L., MERCIER, C.E., and CHENG, E.R.Y. (1991). Differential accumulation of surfactant protein A, B, and C mRNAs in two epithelial cell types of hyperoxic lung. Am. J. Respir. Cell Mol. Biol. 5, 511-515.
22. HOYT, D.G., and LOZO, J.S. (1988). Alterations in pulmonary mRNA encoding procollagens, fibronectin. and transforming growth factor-β precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246, 765-771.
23. KAUFFMAN, S.L. (1980). Cell proliferation in the mammalian lung. Int. Rev. Exp. Pathol. 22, 131-191.
24. KAWADA, H., HORIUCHI, T., SHANNON, J.M., KUROKI, Y., VOELKER, D.R., and MASON, R.J. (1989). Alveolar Type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat. Am. Rev. Respir. Dis. 140, 460-470.
25. KORFHAGEN, T.R., BRUNO, M.D., GLASSER, S.W., CIRAOLO, P.J., WHITSETT, J.A., LATTIER, D.L., WIKENHEISER, K.A., and CLARK, J.C. (1992). Murine pulmonary surfactant SP-A gene: Cloning, sequence and transcriptional activity. Am. J. Physiol. (Lung Cell. Mol. Physiol. 7) 263, L546-L554.
26. KORFHAGEN, T.R., BRUNO, M.D., ROSS, G.F., HUELSMAN, K.M., IKEGAMI, M., JOBE, A.H., WERT, S.E., STRIPP, B.R., MORRIS, R.E., GLASSER, S.W., BACHURSKI, C.J., IWAMOTO, H.S., and WHITSETT, J.A. (1996). Altered surfactant function and structure in SP-A gene targeted mice. Proc. Natl. Acad. Sci. USA 93, 9594-9599.
27. LEVINE, A.M., LOTZE, A., STANLEY, S., STROUD, C., O'DONNELL, R., WHITSETT, J., and POLLACK, M.M. (1996). Surfactant content in children with inflammatory lung disease. Crit. Care Med. 24, 1062-1067.
28. LEVINE, A.M., BRUNO, M.D., HUELSMAN, K.M., ROSS, G.F., WHITSETT, J.A., and KORFHAGEN, T.R. (1997). Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J. Immunol. 7158, 4336-4340.
29. LIN, S., AKINBI, H.T., BRESLIN, J.S., and WEAVER, T.E. (1996a). Structural requirements for targeting of surfactant protein B (SP-B) to secretory granules in vitro and in vivo. J. Biol. Chem. 271, 19689-19695.
30. LIN, S., PHILLIPS, K.S., WILDER, M.R., and WEAVER, T.E. (1996b). Structural requirements for intracellular transport of pulmonary surfactant protein B (SP-B). Biochem. Biophys. Acta 1312, 177-185.
31. MASTRANGELI, A., DANEL, C., ROSENFELD, M.A., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J., and CRYSTAL, R.G. (1993). Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91, 225-234.
32. McCRAY, P.B., ARMSTRONG, K., ZABNER, J., MILLER, D.W., KORETZKY G.A., COUTURE, L., ROBILLARD, J.E., SMITH, A.E., and WELSH, M.J. (1995). Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J. Clin. Invest. 95, 2620-2632.
33. NOGEE, L.M., DEMELLO, D.E., DEHNER, L.P., and COLTEN, H.R. (1993). Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N. Engl. Med. 328, 406-410.
34. NOGEE, L.M., GARNIER, G., DIETZ, H.C., SINGER, L., MURPHY, A.M., DEMELLO, D.E., and COLTEN, H.R. (1994). A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory diseases in multiple kindreds. J. Clin. Invest. 93, 1860-1863.
35. PERÄNEN, J., RIKKONEN, M., and KÄÄRIÄIEN, L. (1993). A method for exposing hidden antigenic sites in paraformaldehyde-fixed cultured cells, applied to initially unreactive antibodies. J. Cytochem. Histochem. 41, 447-454.
36. PISON, U., OBERTACKE, U., SEEGER, W., and HAWGOOD, S. (1992). Surfactant protein-A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur. J. Clin. Invest. 22, 712-718.
37. PISON, U., MAX, M., NEUENDANK, A., WEISSBACH, S., and DIETSCHMANN, S. (1994). Host defense capacities of pulmonary surfactant: Evidence for "non-surfactant" functions of the surfactant system. Eur. J. Clin. Invest. 24, 568-599.
38. PRYHUBER, G.S., CHURCH, S.L., KROFT, T., PANCHAL, A., and WHITSETT, J.A. (1994). 3′-Untranslated region of SP-B mRNA mediated inhibitory effects of TPA and TNF-α on SP-B expression. Am. J. Physiol. (Lung Cell. Mol. Physiol. 11) 267, L16-L24.
39. PRYHUBER, G.S., BACHURSKI, C.J., HIRSCH, R., BACON, A., and WHITSETT, J.A. (1996). Tumor necrosis factor-α decreases surfactant protein B mRNA in murine lung. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 270, L714-L721.
40. RICH, D.P., COUTURE, L.A., CARDOZA, L.M., GUIGGIO, V.M., ARMENTANO, D., ESPINO, P.C., HEHIR, K., WELSH, M.J., SMITH, A.E., and GREGORY, R.J. (1993). Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis, Hum. Gene Ther. 4, 461-576.
41. ROSENFELD, M.A., SIEGFRIED, W., YOSHIMURA, K., YONEYAMA, K., FUKAYAMA, M., STIER, L.E., PÄÄKKÖ, P.K., GILARDI, P., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., JALLAT, S., PAVIRANI, A., LECOCQ, J., and CRYSTAL R.G. (1991). Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
42. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J.-P. and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
43. SIMON, R.H., ENGELHARDT, J.F., YANG, Y., ZEPEDA, M., WEBER-PENDLETON, S., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum. Gene Ther. 4, 771-780.
44. STAHLMAN, M.T., GRAY, M.E., and WHITSETT, J.A. (1992). The ontogeny and distribution of surfactant protein-B in human fetuses and newborns. J. Histochem. Cytochem. 40, 1471-1480.
45. STAHLMAN, M.T., GRAY, M.E., and WHITSETT, J.A. (1996). Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung. J. Histochem. Cytochem. 44, 673-678.
46. THET, L.A., PARRA, S.C., and SCHELBOURNE, J.D. (1988). Sequential changes in lung morphology during the repair of acute oxygen-induced lung injury in adult rats. Exp. Lung Res. 11, 209-228.
47. TOLTOSHEV, P., MITTEREDER, N., YEI, S., and TRAPNELL, B.C. (1994). Adenovirus vectors of gene therapy. In: Cancer Chemotherapy: Challenges for the Future. (Excerpta Medica, Ltd., Tokyo) pp. 23-31.
48. TRAPNELL, B.C. (1993). Adenoviral vectors for gene transfer. Adv. Drug Deliv. Rev. 12, 185-199.
49. TRYKA, A.F., HANSPETER, W., GOSSLEE, D.G., McARTHUR, A.H., and CLAPP, N.K. (1986). Patterns of cell proliferation during recovery from oxygen injury. Am. Rev. Respir. Dis. 133, 1055-1059.
50. VAN GOLDE, L.M. (1995). Potential role of surfactant proteins A and D in innate lung defense against pathogens. Biol. Neonate. 67(Suppl. 1), 2-17.
51. VINCENT, M.C., TRAPNELL, B.C., BAUGHMAN, R.P., WERT, S.E., WHITSETT, J.A., and IWAMOTO, H.S. (1995). Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum. Gene Ther. 6, 1019-1028.
52. VORBROKER, D.K., VOORHOUT, W.F., WEAVER, T.E., and WHITSETT, J.A. (1995a). Posttranslational processing of surfacant protein C in rat Type II cells. Am. J. Physiol. (Lung. Cell Mol. Physiol.) 269, L727-L733.
53. VORBROKER, D.K., PROFITT, S.A., NOGEE, L.M., and WHITSETT, J.A. (1995b). Aberrant processing of surfactant protein C (SP-C) in hereditary SP-B deficiency. Am. J. Physiol. (Lung Cell Mol. Physiol.) 268, L647-L656.
54. WEAVER, T.E., and WHITSETT, J.A. (1991). Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem. J. 273, 249-264.
55. WELSH, M.J., SMITH, A.E., ZABNER, J., RICH, D.P., GRAHAM, S.M., GREGORY, R.J., PRATT, B.M., and MOSCICKI, R.A. (1994). Cystic fibrosis gene therapy using an adenovirus vector: In vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5, 209-219.
56. WIKENHEISER, K.A., WERT, S.E., WISPE', J.R., STAHLMAN, M., D'AMORE-BRUNO, M., SINGH, G., KATYAL, S.L., and WHITSETT, J.A. (1992). Distinct effects of oxygen on surfactant protein B expression in the bronchiolar and alveolar epithelium. Am. J. Physiol. (Lung Cell Mol. Physiol.) 262, L32-L39.
57. WILMOTT, R.W., WHITSETT, J.A., and TRAPNELL, B.C. (1993). A phase I study of gene therapy of cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. Fed. Reg. 58, 8500-8501.
58. WILMOTT, R.W., AMIN, R.S., PEREZ, C.R., WERT, S.E., KELLER, G., BOIVIN, G.P., HIRSCH, R., DE INOCENCIO, J., LU, P., REISING, S.F., YEI, S., WHITSETT, J.A., and TRAPNELL, B.C. (1996). Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA ot the lungs of nonhuman primates. Hum. Gene Ther. 7, 301-318.
59. WILSON, J.M. (1992). Gene therapy of cystic fibrosis lung diseases using E1 deleted adenovirus: A phase I trial. Fed. Reg. 57, 49584.
60. WISPÈ, J., CLARK, J., HULL, W., HOLTZMAN, R., and WHITSETT, J.A. (1990). Tumor necrosis factor alpha inhibits surfactant-associated protein A expression. Am. Rev. Respir. Dis. 141, A692.
61. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GÖNCZÖL, E., and WILSON, J.M. (1994a). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
62. YANG, Y., NUNES, F.A., BERENCSI, K., GÖNCZÖL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994b). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
63. YEI, S., BACHURSKI, C.J., WEAVER, T.E., WERT, S.E., TRAPNELL, B.C., and WHITSETT, J.A. (1994a). Adenoviral-mediated gene transfer of human surfactant protein B to respiratory epithelial cells. Am. J. Respir. Cell Mol. Biol. 11, 329-336.
64. YEI, S., MITTEREDER, N., WERT, S., WHITSETT, J.A., WILMOTT, R.W., and TRAPNELL, B.C. (1994b). In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5, 731-744.
65. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
66. ZHOU, L., LIM, L., COSTA, R.H., and WHITSETT, J.A. (1996). Thyroid transcription factor-1, hepatocyte nuclear factor-3β, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J. Histochem. Cytochem. 44, 1183-1193.
67. ZSENGÉLLER, Z.K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 457-467.